We investigated how innate sensing by the mannose receptor (MR) influences the development of antifungal immunity. We demonstrate that MR senses mannan on the surface of attenuated Blastomyces dermatitidis vaccine yeast and that MR
The cell wall of medically important fungi contains 3 major polysaccharides: β-glucan, chitin, and mannan [1] . β-(1,3)-glucans containing covalent links to β-(1,6)-glucan and chitin form the core structural component. Mannoproteins that are glycosylated via N and O linkages are attached to this skeleton. Whereas mammalian proteins rarely have exposed mannose residues, fungi use mannose as their preferred sugar [2] . Highly mannosylated polysaccharides are referred to as mannans, and in the cell wall of Candida albicans, chains comprising up to 200 mannose groups can be found [1, 2] . Importantly, mannans tend to be on the outer fungal cell wall, whereas β-glucans are largely on the inside. Recognition of mannan through a combination of pattern-recognition receptors (PRRs), including Ctype lectin receptors, promotes antifungal immune responses [3, 4] . Notably, mannan has been shown to induce T-helper type 17 (Th17) responses in a C. albicans infection model [5] [6] [7] . Although Th17 cells play a requisite role in antifungal responses [8] , the role of PRRs that recognize mannan and induce differentiation of Th17 cells have not been fully elucidated.
MR was reported to trigger Th17 cells in response to C. albicans [6, 7] . The design of that study involved stimulation of human mononuclear cells in vitro in the presence of C. albicans, its components, and blocking antibody against MR. Despite strong MR-dependent responses in that study, human memory T cells (CD44 hi ) and not naive T cells were the main source of interleukin 17 (IL-17) produced, owing to the high frequency of exposure to Candida in the general population. Since cytokines required to prime naive T cells differ from those that propagate already primed memory T cells, the experimental design of that study did not address whether MR induces Th17 cell differentiation of naive T cells. Here, we took advantage of an adoptive transfer system in which we can transfer naive antifungal T cells into recipient mice to investigate the role of host factors or receptors. We studied how naive T cell differentiation into Th17 cells is influenced by development in MR-deficient hosts. We report that MR is required not only for recall of memory responses, but also for differentiation of naive T cells into Th17 effector cells and optimal induction of vaccine resistance against Blastomyces dermatitidis infection.
MATERIALS AND METHODS

Fungal Cultures
B. dermatitidis strains used were ATCC 26199, a wild-type virulent strain, and the isogenic, attenuated mutant lacking BAD1, designated strain 55 [9] . Isolates of B. dermatitidis were maintained as yeast on Middlebrook 7H10 agar with oleic acidalbumin complex (Sigma) at 39°C.
Mouse Strains
Inbred wild-type C57BL/6 were obtained from Jackson Laboratories (Bar Harbor, Maine). Blastomyces-specific T-cell receptor (TCR) transgenic (Tg) 1807 mice were generated in our laboratory and were backcrossed to congenic Thy1.1 + mice as described elsewhere [10] . MR −/− mice were a generous gift from Dr Stuart Levitz at the University of Massachusetts, who sent us the mice with the permission of Dr Michele Nussenzweig [11] . All mice were 7-8 weeks old at the time of experiments. Mice were housed and cared for according to guidelines of the University of Wisconsin Animal Care Committee, who approved all aspects of this work. 
Vaccination and Experimental Infection
Mice were vaccinated subcutaneously with 10 6 -10 7 strain 55 yeast dorsally twice over 4 weeks and were infected intratracheally with 2 × 10 3 or 2 × 10 4 isogenic, wild-type B. dermatitidis strain 26199 yeast as described previously [8] . At day 4 after infection, lung T cells were analyzed by FACS analysis. The burden of lung infection was determined by plating lung homogenates on brain-heart infusion (Difco) agar, followed by enumeration of colony-forming units (CFUs).
Adoptive Transfer of Transgenic 1807T Cells and Intracellular Cytokine Staining
A total of 10 6 magnetic bead-purified CD4 + cells from TCR Tg 1807 (Thy1.1 + ) mice were injected intravenously into Thy1.2 + C57BL/6 recipients prior to vaccination. At day 4 after infection, lung T cells were enumerated as described previously [8] . Anti-CD3 and anti-CD28 monoclonal antibody (mAb)-stimulated cells were stained with anti-interferon γ (IFN-γ) and anti-IL-17-mAbs as described previously [8] . FACS data were gathered with an LSRII flow cytometer, and data were analyzed with FlowJo software (Tree Star).
Ex Vivo Coculture for Cytokine Protein Measurement
Splenocytes were harvested from mice at day 34 after vaccination, washed, stimulated in complete RPMI 1640 medium containing 10 µg/mL yeast cell-wall-membrane antigen [13] , and plated in 24-well plates at a concentration of 3 × 10 6 cells/well.
Five days later, supernatants were collected, and IFN-γ and IL-17 expression were measured in cell culture supernatants by ELISA (R&D Systems).
Real-Time Polymerase Chain Reaction (PCR) Analysis for IFN-γ and IL-17 Transcripts
Total RNA was isolated from lung homogenates at day 4 after infection, using the Qiagen RNeasy kit. Genomic DNA was removed using Turbo DNase (Ambion), the RNA was cleaned using Qiagen RNeasy columns, and complementary DNA (cDNA) was synthesized using the iScript cDNA Synthesis Kit (Bio-Rad). Real-time PCR was performed with iQ SYBR Green Supermix (Bio-Rad), and the reactions were run on a MyiQ real-time PCR detection system (Bio-Rad). The n-fold change of gene expression for MR −/− versus wild-type controls was calculated using the comparative cycle threshold method.
Statistical Analysis
Differences in the numbers and percentages of activated or cytokine-producing T cells were analyzed using the Wilcoxon rank test for nonparametric data or the t test (using GraphPad Prism) when data were normally distributed [14] . Factorial analysis of variance using SAF software was used to compare the vaccine-induced reduction in lung CFUs between different strains of mice. P < .05 is considered statistically significant.
RESULTS AND DISCUSSION
Mannan on the B. dermatitidis Cell Wall Drives IL-17 Production
Many fungal cell wall proteins are modified by N-linked mannosylation, O-linked mannosylation, and phosphomannosylation [7] . To investigate whether the cell wall of B. dermatitidis harbors mannan on its surface, we stained yeast with ConA FITC. Abundant mannan was found to decorate the surface of the yeast ( Figure 1A ). Since MR recognizes fungal mannan and induces IL-17 by human memory T cells in response to C. albicans in vitro [6] , we investigated whether soluble mannan affects the production of IL-17 by naive B. dermatitidis-specific 1807 T cells induced in response to the yeast. Soluble mannan inhibited IL-17 production by 1807 T cells in a concentrationdependent manner ( Figure 1B ). Surface-exposed mannans are recognized by multiple PRRs, including MR. To investigate whether IL-17 production requires the presence of MR on antigen-presenting cells, we cocultured MR (Figure 1D ). These data indicate that yeast uptake by MR skews the cytokine profile of activated BMDCs but not the rate of yeast uptake.
MR Is Required for the Differentiation of Th17 Cells and Protection In Vivo
To (Figure 2A and 2B). The number of IFN-γ-producing 1807 cells was reduced 3-fold, but that difference was found to be statistically insignificant. Lung transcripts for IL-17 but not those for IFN-γ were also reduced in vaccinated (and unvaccinated) MR −/− mice, compared with wild-type mice, at day 4 after infection ( Figure 2C ). IL-17 and IFN-γ protein levels were reduced by splenic CD4 + T cells that were stimulated ex vivo with cell- wall-membrane antigen ( Figure 2C ). Thus, MR is required for the development and recruitment of antifungal Th17 cells to the lungs. Since we adoptively transferred naive fungus-specific 1807 T cells, we can definitively conclude that MR regulates differentiation of naive antifungal T cells into effector Th17 cells. Our observation therefore significantly extends the findings of T cells. Data are representative of 2 independent experiments. *P < .05 vs yeast-stimulated, non-mannan-treated controls. C, Cytokine transcripts in lung homogenates were analyzed at day 4 after infection, and cytokine levels were measured in ex vivo-stimulated splenocytes. D, The lung burden was assessed at day 4 and 2 weeks after infection. Data are the average and SEMs of 3 independent experiments. *P < .05 vs infected wild-type controls. Abbreviations: CFUs, colony-forming units; IFN-γ, interferon γ; IL-17, interleukin 17.
other work in which MR was the main receptor that triggered the production of IL-17 in response to Candida mannan by memory CD4 + T cells that were already committed Th17 cells [6] .
To test whether MR is required for vaccine-induced protection against B. dermatitidis infection, we immunized MR −/− mice and wild-type controls and enumerated lung CFUs at day 4 and day 14 after challenge. At both time points, unvaccinated MR −/− mice had a burden of lung infection similar to that of unvaccinated wild-type controls, suggesting that MR does not contribute to innate defense ( Figure 2D ). However, vaccinated MR −/− mice showed 84-and 53-fold higher lung CFUs than vaccinated wild-type controls at days 4 and 14, respectively ( Figure 2D ). Thus, MR is required for optimal protection induced by the vaccine. Since we previously demonstrated that Th17 cells are indispensable for mediating vaccine immunity to B. dermatitidis and other systemic dimorphic fungi, it is likely that the reduced numbers of Th17 cells in MR −/− mice were responsible for the impaired resistance. Taken together, our findings indicate that MR recognizes a mannan-like structure on the B. dermatitidis cell wall that leads to the differentiation of naive antifungal T cells into Th17 effector cells mediating vaccine-induced resistance. An intriguing idea is that mannoproteins that contain immunodominant T-cell epitopes could be the source of mannans that skew cytokine induction by antigen-presenting cells and influence Th17 cell differentiation. Thus, MR ligands could be harnessed as adjuvants and benefit the rational design of new T-cell-based antifungal vaccines. 
